Stonepine Capital Management, LLC Portfolio Holdings

Stonepine Capital Management, LLC

  • $158 Billion
  • Q3 2024

Stonepine Capital Management, LLC has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $158 Billion distributed in 38 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Adma Biologics, Inc. with a value of $37.4B, Evolus, Inc. with a value of $22.2B, Galapagos Nv with a value of $13.8B, Jazz Pharmaceuticals PLC with a value of $6.13B, and Royalty Pharma PLC with a value of $6B.

Examining the 13F form we can see an increase of $48.6B in the current position value, from $110B to 158B.

Stonepine Capital Management, LLC is based out at Bend, OR

Below you can find more details about Stonepine Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $158 Billion
Healthcare: $142 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$11.2B
$6 Billion 3.79% of portfolio
212,000
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 38
  • Current Value $158 Billion
  • Prior Value $110 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 17 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email